FOMAT

Cardiovascular and circulatory diseases

FOMAT Prime Therapeutic Areas provide highly specialized research sites with robust infrastructure, experienced investigators, and proven recruitment models. In Cardiovascular and Circulatory Disease, we support trials focused on hypertension, coronary artery disease, atrial fibrillation, hyperlipidemia, and heart failure, supported by integrated monitoring, strong patient access, and consistent site execution.
Participants enrolled in this heart failure trial
0
Patients in the cardiovascular patient database
0
Retention rate in cardiovascular study
0 %
Meeting or exceeding target enrollment for diverse patient populations
0 %+

Cardiovascular and circulatory disease trial capabilities

Our cardiovascular trial capabilities include integrated monitoring and diagnostic access, experienced clinical research teams, and reliable operational support. We ensure consistent trial delivery with standardized processes and strong patient reach across cardiovascular populations. 
  • Monitoring and testing capabilities including blood pressure monitoring, ECG access, Holter and rhythm monitoring access, oxygen saturation monitoring, and related cardiovascular assessments
  • Diagnostic and imaging capabilities including ECG, echocardiography access, vascular ultrasound and Doppler study access, and ambulatory blood pressure monitoring
  • Multi location patient access across California research sites and referral locations
  • Integrated EHR, CTMS, eSource or eCRFs, eReg, and eConsent systems
  • Experienced research teams with dedicated operational support and quality oversight
Cardiovascular and Circulatory Diseases | FOMAT

Key differentiators

Reliable start-up execution

Dedicated regulatory and operational support teams streamline activation and help drive predictable study start timelines. 

Experienced cardiovascular investigators

Board certified investigators with extensive cardiovascular clinical and research experience across hypertension, atrial fibrillation, coronary artery disease, hyperlipidemia, and heart failure populations. 

Real time data management

Integrated platforms (EHR, CTMS, eSource or eCRFs, eReg, eConsent) support continuous documentation workflows and timely data readiness.

Comprehensive recruitment and retention

Demonstrated enrollment and retention performance, including 92% retention in a recent heart failure study (13 enrolled vs 4 target), supported by coordinated site operations and patient engagement practices. 

Infrastructure for all study phase

Clinical sites and supporting infrastructure enable cardiovascular trial execution with monitoring, diagnostics, data systems, and operational support aligned to study needs.